| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2007 | CA2653136A1 Heterobicylic metalloprotease inhibitors |
| 12/06/2007 | CA2653131A1 Heterobicyclic metalloprotease inhibitors |
| 12/06/2007 | CA2653076A1 Pyrazolo [1, 5-a] pyrimidines as cdk inhibitors |
| 12/06/2007 | CA2653072A1 Method for elevating prolactin in mammals |
| 12/06/2007 | CA2653023A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid or sa lt thereof |
| 12/06/2007 | CA2653005A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 12/06/2007 | CA2652990A1 Therapeutic cyclopentane derivatives |
| 12/06/2007 | CA2652958A1 Deoxynojirimycin and d-arabinitol analogs and methods of using |
| 12/06/2007 | CA2652926A1 Drug combinations with substituted diaryl ureas for the treatment of cancer |
| 12/06/2007 | CA2652888A1 Methods and compositions using immunomodulatory compounds in combination therapy |
| 12/06/2007 | CA2652869A1 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 12/06/2007 | CA2652809A1 Methods of maintaining and using a high concentration of dissolved copper on the surface of a useful article |
| 12/06/2007 | CA2652773A1 Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels |
| 12/06/2007 | CA2652735A1 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 12/06/2007 | CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
| 12/06/2007 | CA2652501A1 Novel heterocyclic compound or salt thereof and intermediate thereof |
| 12/06/2007 | CA2652205A1 Low molecular weight heparin composition and uses thereof |
| 12/06/2007 | CA2652167A1 Pyrrolo[1,2-a]pyrazin-1(2h)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2h)-one derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 12/06/2007 | CA2652164A1 Compounds for the treatment of alzheimer's disease |
| 12/06/2007 | CA2652158A1 Piperidinyl pyrimidine derivatives |
| 12/06/2007 | CA2652044A1 Pyrrolopyrimidine compounds and their uses |
| 12/06/2007 | CA2651979A1 Triazolopyridazine derivatives |
| 12/06/2007 | CA2651857A1 Aryl-4-ethynyl-isoxazole derivatives |
| 12/06/2007 | CA2651849A1 Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
| 12/06/2007 | CA2651737A1 Barrier film-forming germicidal composition for controlling mastitis |
| 12/06/2007 | CA2651716A1 Duloxetine hydrochloride delayed release formulations |
| 12/06/2007 | CA2651710A1 Substituted 5-phenylamino-1,3,4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 12/06/2007 | CA2651663A1 Chemical compounds |
| 12/06/2007 | CA2651659A1 Lysine related derivatives as hiv aspartyl protease inhibitors |
| 12/06/2007 | CA2651549A1 Aldosterone synthase and/or 11.beta.-hydroxylase inhibitors |
| 12/06/2007 | CA2651454A1 Imidazoazephinone compounds |
| 12/06/2007 | CA2651373A1 Compounds and methods for modulating fxr |
| 12/06/2007 | CA2651368A1 Tumor suppressor |
| 12/06/2007 | CA2650833A1 Autodestructive transdermal therapeutic system |
| 12/06/2007 | CA2650622A1 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists |
| 12/06/2007 | CA2650514A1 Salts and crystal modifications thereof |
| 12/06/2007 | CA2650147A1 Benzazepine derivatives as monoamine reuptake inhibitors |
| 12/06/2007 | CA2648987A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
| 12/06/2007 | CA2647598A1 Compounds as cannabinoid receptor ligands and uses thereof |
| 12/06/2007 | CA2647597A1 Thiazole compounds as cannabinoid receptor ligands and uses thereof |
| 12/06/2007 | CA2647592A1 Inhibitors of polo-like kinases |
| 12/06/2007 | CA2644524A1 Method of enhancing the control of viruses on skin |
| 12/06/2007 | CA2637803A1 Ppar modulators |
| 12/06/2007 | CA2636101A1 Hydrophilized anode for a direct liquid fuel cell |
| 12/05/2007 | EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 12/05/2007 | EP1862472A2 Chlamydia protein, gene sequence and uses thereof |
| 12/05/2007 | EP1862470A1 Element retained in blood showing degradability selectively in tumor tissue |
| 12/05/2007 | EP1862469A2 New solid forms of mesoprogestin 11Beta-[4E-(hydroxyimino methyl)-phenyl]-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on |
| 12/05/2007 | EP1862468A1 Crystalline 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one |
| 12/05/2007 | EP1862466A2 Arrays with cleavable linkers |
| 12/05/2007 | EP1862464A1 Novel cyclic aminophenylalkanoic acid derivative |
| 12/05/2007 | EP1862463A1 Pyrimidine compound crystal or amorphous form and process for producing the same |
| 12/05/2007 | EP1862462A1 Process for the preparation of desloratadine |
| 12/05/2007 | EP1862459A1 Novel heterocyclic compounds |
| 12/05/2007 | EP1862458A2 Therapeutic agents useful for treating pain |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862455A2 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-undecanoic acid |
| 12/05/2007 | EP1862454A1 Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862450A2 Novel compounds |
| 12/05/2007 | EP1862444A2 Ether compounds, compositions, and uses thereof |
| 12/05/2007 | EP1862184A1 Pharmaceutical composition |
| 12/05/2007 | EP1862183A1 Pharmaceutical composition containing hardly water soluble medicament |
| 12/05/2007 | EP1862181A2 Combination therapy using an 11B-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders |
| 12/05/2007 | EP1862179A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| 12/05/2007 | EP1862172A1 Combination of amino acid solution and a gelatin for inhibiting renal uptake |
| 12/05/2007 | EP1862168A1 Method of treating liver cancer |
| 12/05/2007 | EP1862167A2 Methods and formulations for the treatment of female sexual dysfunction |
| 12/05/2007 | EP1862166A1 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| 12/05/2007 | EP1862165A2 Prevention and treatment of androgen-deprivation induced hot flashes |
| 12/05/2007 | EP1862164A2 Dry powder for inhalation |
| 12/05/2007 | EP1862163A1 L-Carnitin for supression of crystallisation |
| 12/05/2007 | EP1862161A1 Injectable pharmaceutical, cosmetic compositions and/or medical devices on the basis of hyaluronic-acid |
| 12/05/2007 | EP1862071A2 Sterilization solution and method for manufacturing sterilization solution |
| 12/05/2007 | EP1861496A2 Inhibition of spag9 expression with sirnas |
| 12/05/2007 | EP1861491A1 Flavivirus replicon constructs for tumour therapy |
| 12/05/2007 | EP1861490A1 The use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota |
| 12/05/2007 | EP1861427A2 Agglomerated starch compositions |
| 12/05/2007 | EP1861412A1 Adenosine derivatives having a2a receptor activity |
| 12/05/2007 | EP1861411A2 Novel compounds derived from 5-thioxylose and therapeutic use thereof |
| 12/05/2007 | EP1861410A1 Glycolipids of branched chain alkyl oligosaccharides for liquid crystal and related applications |
| 12/05/2007 | EP1861407A1 Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| 12/05/2007 | EP1861406A2 Hydrocodone polymorphs |
| 12/05/2007 | EP1861404A1 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid |
| 12/05/2007 | EP1861403A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/05/2007 | EP1861402A1 Isoflavonoid dimers |
| 12/05/2007 | EP1861401A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 12/05/2007 | EP1861400A1 Crystal forms of an imidazole derivative |
| 12/05/2007 | EP1861399A2 Cgrp receptor antagonists |
| 12/05/2007 | EP1861396A1 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity |
| 12/05/2007 | EP1861395A1 5-(1,3-diaryl-1h-pyrazol-4-ylmethylene)-thiazolidine-2,4-dione derivatives useful as anticancer agent |
| 12/05/2007 | EP1861394A1 Substituted pyridine derivatives |
| 12/05/2007 | EP1861393A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 12/05/2007 | EP1861392A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof |
| 12/05/2007 | EP1861391A1 Substituted sulfoxide compounds, methods for preparing the same and use thereof |
| 12/05/2007 | EP1861390A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 12/05/2007 | EP1861389A1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 12/05/2007 | EP1861388A1 Potassium channel modulating agents and their medical use |
| 12/05/2007 | EP1861387A1 Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 12/05/2007 | EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors |